Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
Lauren Shapiro, Astha Thakkar, Sean Campbell, Stefanie Forest, Kith Pradhan, Jesus D. Gonzalez‐Lugo, Ryann Quinn, Tushar D. Bhagat, Gaurav S. Choudhary, Margaret McCort, R. Alejandro Sica, Mendel Goldfinger, Swati Goel, Jesus D. Anampa, David Levitz, Ariel Fromowitz, Akash Shah, Charlotte Sklow, Gregory Alfieri, Andrew D. Racine, Lucia R. Wolgast, Lee M. Greenberger, Amit Verma, Balázs Halmos
Topics & Concepts
Booster (rocketry)MedicineVaccinationImmunityClinical trialImmune systemImmunologyBooster doseCoronavirus disease 2019 (COVID-19)TiterDosingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CD20VirologyAntibodyInternal medicineImmunizationInfectious disease (medical specialty)DiseaseAstronomyPhysicsSARS-CoV-2 and COVID-19 ResearchCancer Immunotherapy and BiomarkersCOVID-19 and healthcare impacts